Ultralife (ULBI) Research & Development (2010 - 2026)

Ultralife has reported Research & Development for 17 years, with the latest figure at $3.2 million in Q2 2026.

• On a quarterly basis, Research & Development rose 39.13% year-over-year to $3.2 million in Q2 2026; TTM through Jun 2026 was $13.5 million, a 28.76% increase from a year earlier, with the FY2025 full-year figure at $12.1 million, up 26.49% from the prior year.
• Research & Development was $3.2 million for Q2 2026 at Ultralife, up from $3.0 million in the prior quarter.
• The five-year high for Research & Development was $4.5 million in Q4 2025, with the low at $1.7 million in Q2 2022.
• Average Research & Development over 5 years is $2.5 million, with a median of $2.2 million recorded in 2024.
• The sharpest annual moves came in 2024 and 2026: Research & Development retreated 13.58% in 2024, then soared 39.13% in 2026.
• Over 5 years, Research & Development stood at $2.4 million in 2022, then gained by 18.74% to $2.9 million in 2023, then increased by 27.06% to $3.7 million in 2024, then gained by 21.84% to $4.5 million in 2025, then declined by 28.37% to $3.2 million in 2026.
• The last three Research & Development figures came in at $3.2 million (Q2 2026), $3.0 million (Q1 2026), and $4.5 million (Q4 2025), per Business Quant data.